What problems do gastric cancer patients face?

Gastric cancer patients may face the risk of total gastrectomy depending on the size and location of the tumor, leading to a decrease in quality of life and requiring lifelong nutritional supplementation.

What is "perioperative immunotherapy"?

"Perioperative immunotherapy" is a three-stage treatment consisting of neoadjuvant therapy before surgery, surgery, and adjuvant therapy after surgery. It aims to shrink tumors, improve surgical success rates, enhance postoperative quality of life, and reduce the risk of recurrence and metastasis.

AI News NQ Analysis

Helping Gastric Cancer Patients Maintain Quality of Life: Doctors Reveal New "Perioperative" Treatment Method

NQ Score 90/100

AI Summary (NQ-processed)

Gastric cancer patients face risks of total gastrectomy, impacting quality of life. "Perioperative immunotherapy" shows promise in reducing recurrence, metastasis, and postoperative mortality. This treatment can potentially reduce recurrence risk by 30% and mortality risk by 20% compared to traditional chemotherapy.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What problems do gastric cancer patients face?: A: Gastric cancer patients may face the risk of total gastrectomy depending on the size and location of the tumor, leading to a decrease in quality of life and requiring lifelong nutritional supplementation.
Q: What is "perioperative immunotherapy"?: A: "Perioperative immunotherapy" is a three-stage treatment consisting of neoadjuvant therapy before surgery, surgery, and adjuvant therapy after surgery. It aims to shrink tumors, improve surgical success rates, enhance postoperative quality of life, and reduce the risk of recurrence and metastasis.